Last reviewed · How we verify

NCT05232981: PASIIL

Conservative Treatment of PAS With or Without IIL

Status unknown NA Last updated 28 February 2024
What this trial tests

NA trial testing Ligation of the bilateral internal iliac arteries in Placenta Accreta in 90 participants. Status unknown.

Timeline
1 May 2022
Primary endpoint
1 October 2024
1 October 2024

Quick facts

Lead sponsorTanta University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment90
Start date1 May 2022
Primary completion1 October 2024
Estimated completion1 October 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 20 to 35, female only, with Placenta Accreta or Cesarean Hysterectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the current study, the investigators aimed to compare the benefits of internal iliac ligation in placenta accreta spectrum

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Placenta Accreta

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05232981.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing